NCT02243592 2026-04-17
Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment
National Cancer Institute (NCI)
Active not recruiting
Clinical Trials
161 trialsNCT02688517 2026-04-17
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
Rutgers, The State University of New Jersey
Recruiting
NCT02834884 2026-04-17
SPECTA
European Organisation for Research and Treatment of Cancer - EORTC
Recruiting
NCT03617237 2026-04-17
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation
University of Texas Southwestern Medical Center
Recruiting
NCT04452825 2026-04-17
A New Psychotherapy Intervention for Older Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT07258836 2026-04-17
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
Eli Lilly and Company
Phase 1 Recruiting
NCT07535918 2026-04-17
Using e-Technologies to Maximize Physical Activity After Cancer Treatment
University of Florida
Phase NA Not yet recruiting
NCT02911064 2026-04-16
Expectations Regarding Mobility and Self-Care
M.D. Anderson Cancer Center
Active not recruiting
NCT05836857 2026-04-16
The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study
M.D. Anderson Cancer Center
Active not recruiting
NCT06329531 2026-04-16
Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic
M.D. Anderson Cancer Center
Recruiting
NCT06959706 2026-04-16
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Tagworks Pharmaceuticals BV
Phase 1 Recruiting
NCT07326800 2026-04-16
MAEva-MCT
Institut de Cancérologie de Lorraine
Phase NA Recruiting
NCT01481532 2026-04-15
Open Label Clinical Trial of Intravenous Crotoxin Part 3
Celtic Biotech Ltd
Phase 1 Not yet recruiting
NCT02337452 2026-04-15
Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families
M.D. Anderson Cancer Center
Active not recruiting
NCT04464226 2026-04-15
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
Bayer
Phase 3 Active not recruiting
NCT05376891 2026-04-15
Met Non Small Cell Cancer Registry (MOMENT)
EMD Serono
Recruiting
NCT07005102 2026-04-15
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
AbbVie
Phase 2/3 Recruiting
NCT07342335 2026-04-15
Breaking Barriers to Research Access
The Clatterbridge Cancer Centre NHS Foundation Trust
Recruiting
NCT07528547 2026-04-15
Peds Ethos
University Health Network, Toronto
Phase NA Recruiting
NCT07532018 2026-04-15
DXP-106
Singlomics (Beijing DanXu) Biopharmaceuticals Co., Ltd.
Phase 1 Recruiting
NCT07532083 2026-04-15
Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery
University of Wisconsin, Madison
Recruiting
NCT00026650 2026-04-14
Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy
National Institutes of Health Clinical Center (CC)
Recruiting
NCT00923065 2026-04-14
Data Collection, Clinical Care and Interventions in CCR, NCI
National Institutes of Health Clinical Center (CC)
Enrolling by invitation
NCT02154022 2026-04-14
Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity
National Institutes of Health Clinical Center (CC)
Enrolling by invitation
NCT03768336 2026-04-14
A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors
Massachusetts General Hospital
Phase NA Active not recruiting
NCT03956459 2026-04-14
IQversusMI
Institut Claudius Regaud
Phase NA Completed
NCT04442425 2026-04-14
Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain
National Institutes of Health Clinical Center (CC)
Completed
NCT04958239 2026-04-14
A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer
Boehringer Ingelheim
Phase 1 Active not recruiting
NCT05088395 2026-04-14
ALCINA4
Institut Curie
Phase NA Recruiting
NCT05350761 2026-04-14
Rare Tumors and Cancer Predisposition in Individuals and Families
National Institutes of Health Clinical Center (CC)
Recruiting
NCT05382559 2026-04-14
A Study of ASP3082 in Adults With Advanced Solid Tumors
Astellas Pharma Inc
Phase 1 Recruiting
NCT05611632 2026-04-14
NHS-Galleri
GRAIL, Inc.
Phase NA Active not recruiting
NCT06150157 2026-04-14
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Janssen Research & Development, LLC
Phase 1 Recruiting
NCT07369778 2026-04-14
IMPULSION
Nantes University Hospital
Not yet recruiting
NCT07527416 2026-04-14
Testi AYA
Centro di Riferimento Oncologico - Aviano
Recruiting
NCT02908906 2026-04-13
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
Janssen Research & Development, LLC
Phase 1/2 Active not recruiting
NCT03148418 2026-04-13
A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)
Hoffmann-La Roche
Phase 3 Active not recruiting
NCT03621124 2026-04-13
Maladaptive Adipose Tissue Activity in Cancer
Virginia Commonwealth University
Terminated
NCT04606381 2026-04-13
PALOMA
Janssen Research & Development, LLC
Phase 1 Active not recruiting
NCT05120596 2026-04-13
First in Human Study of T3P-Y058-739 (T3P)
T3 Pharmaceuticals AG
Phase 1/2 Recruiting
NCT05155605 2026-04-13
PATHFINDER 2: A Multi-Cancer Early Detection Study
GRAIL, Inc.
Phase NA Active not recruiting
NCT05377554 2026-04-13
Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery
Alume Biosciences, Inc.
Phase 3 Completed
NCT05465161 2026-04-13
StingMark
Centre hospitalier de l'Université de Montréal (CHUM)
Phase NA Recruiting
NCT05862285 2026-04-13
UmbrellaMAX
Hoffmann-La Roche
Phase 3 Recruiting
NCT05879146 2026-04-13
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT05909202 2026-04-13
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
National Institutes of Health Clinical Center (CC)
Phase NA Completed
NCT05937659 2026-04-13
Incorporating Biometric Data for Patients Receiving Concurrent Chemotherapy & RT
UNC Lineberger Comprehensive Cancer Center
Not yet recruiting
NCT06178614 2026-04-13
A Study of JNJ-87890387 for Advanced Solid Tumors
Janssen Research & Development, LLC
Phase 1 Recruiting
NCT06319378 2026-04-13
CAPSI
Section for Affective Disorders; Northern Stockholm Psychiatry
Phase 2 Recruiting
NCT06609473 2026-04-13
CHEF
Dana-Farber Cancer Institute
Phase NA Recruiting